183 related articles for article (PubMed ID: 12082100)
1. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin.
Tseng YH; Ueki K; Kriauciunas KM; Kahn CR
J Biol Chem; 2002 Aug; 277(35):31601-11. PubMed ID: 12082100
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of insulin receptor substrates in brown adipocyte differentiation.
Tseng YH; Kriauciunas KM; Kokkotou E; Kahn CR
Mol Cell Biol; 2004 Mar; 24(5):1918-29. PubMed ID: 14966273
[TBL] [Abstract][Full Text] [Related]
3. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
4. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
6. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
8. Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.
Winnay JN; Brüning JC; Burks DJ; Kahn CR
J Biol Chem; 2000 Apr; 275(14):10545-50. PubMed ID: 10744748
[TBL] [Abstract][Full Text] [Related]
9. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
[TBL] [Abstract][Full Text] [Related]
10. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Brüning JC; Winnay J; Cheatham B; Kahn CR
Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
13. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
14. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
Annerén C; Welsh M
Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
[TBL] [Abstract][Full Text] [Related]
16. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis.
Valverde AM; Kahn CR; Benito M
Diabetes; 1999 Nov; 48(11):2122-31. PubMed ID: 10535444
[TBL] [Abstract][Full Text] [Related]
17. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
18. Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes.
Arribas M; Valverde AM; Benito M
J Biol Chem; 2003 Nov; 278(46):45189-99. PubMed ID: 12944402
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
Welsh N; Makeeva N; Welsh M
Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
[TBL] [Abstract][Full Text] [Related]
20. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
Lassarre C; Ricort JM
Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]